Urine-Based Molecular Testing Service

CPV: Health services

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Unspecified in notice

Recurring procurement

Unspecified in notice

First published

9 Nov 2026, 15:29 GMT

Last source update

9 Nov 2026, 15:29 GMT

Authority reference

MED9962

FTS notice number

2026/S 000-106341

Classification (CPV)

Health services

Delivery area

West Midlands (UKG23)

Official registry OCID

ocds-h6vhtk-07b7d7 Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by midnight on Thursday 19 November 2026. This contract has not yet formally been awarded; this notice services as an intention to award under the PSR.

Publisher note: This is a Provider Selection Regime (PSR) Intention to Award Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Thursday 19 November 2026. <br/><br/>This contract has not been formally awarded: this serves as an intention to award under the PSR. <br/><br/>Representations should be issued to [email protected]. <br/><br/>The Award Decision Makers are: <br/><br/>Procurement Lead (Head of Procurement - Medical Strategic)<br/>Divisional Business Advisor (Head of Operations - Surgical Division)<br/>Deputy Group Director of Procurement<br/>Deputy Chief Finance Officer<br/><br/>No declared Conflicts of Interest were received as part of the decision-making process. <br/><br/>The Trust undertook an assessment against the following key criteria: <br/><br/>KC1: Quality and Innovation (Weighting 30%)<br/>KC2: Value (Weighting 25%)<br/>KC3: Integration, Collaboration and Service Sustainability (Weighting 15%)<br/>KC4: Improving Access, Reducing Health Inequalities and Facilitating Choice (Weighting 20%)<br/>KC5: Social Value (Weighting 10%)<br/><br/>The weightings were allocated in accordance with the relative importance in line with the Service Specification. <br/><br/>Following an internal assessment, it was identified that Informed Genomics (t/a Nonacus Clinical Services) met the Key Criteria to a sufficient standard.

• Informed Genomics Trading as Nonacus Clinical ServicesAwarded supplier Unit 5 Quinton Business Park, Quinton, West Midlands, B32 1AF

No document links were published on the notice.